ACI HealthCare Limited

ACI HealthCare Limited (AHL) is a specialized public limited subsidiary of Advanced Chemical Industries (ACI) PLC, established on 18 February 2013. The company focuses on pharmaceutical manufacturing, with an emphasis on quality, regulatory compliance and participation in regulated international healthcare markets.

Company background

ACI HealthCare Limited carries forward a pharmaceutical and chemical industry heritage connected to the history of ACI PLC in Bangladesh. Its purpose is to strengthen pharmaceutical manufacturing capability and develop products and manufacturing systems that can meet the requirements of highly regulated markets.

The company describes its strategic direction around regulated-market manufacturing and global healthcare access, with particular attention to markets such as the United States, Europe and other advanced international markets. This requires consistent manufacturing processes, disciplined operational management, quality systems and alignment with applicable regulatory expectations.

Manufacturing facility

ACI HealthCare Limited has developed a manufacturing campus on approximately 39 acres in Sonargaon, Narayanganj. The facility is designed to support multi-product pharmaceutical manufacturing in controlled and compliant environments.

The manufacturing campus incorporates validated systems, structured material flow and data-governed operations. In simple terms, these systems are intended to help ensure that manufacturing activities are controlled, documented and performed consistently. The company describes its approach as a lifecycle quality mindset, where processes are understood, risks are evaluated and improvements are made continuously.

Quality and regulatory focus

Quality is a central part of ACI HealthCare Limited's operating approach. The company emphasizes regulatory discipline, risk evaluation, process control and continuous improvement as part of its manufacturing and quality framework.

Its strategic mandate is designed around regulated markets, where pharmaceutical manufacturers must maintain controlled processes and meet applicable regulatory requirements. The company specifically identifies alignment with regulatory bodies such as the US FDA and other internationally recognized authorities as an important part of its direction.

International market focus

ACI HealthCare Limited is structured to participate in quality-driven international healthcare markets. Its stated areas of engagement include the United States, Europe, the Middle East and North Africa, Asia Pacific and Latin America.

The company's operating model emphasizes regulatory alignment, reliable supply performance and lifecycle quality governance. Its stated future priorities include biosimilars, selected API backward integration, and advanced delivery and controlled-release platforms, which are intended to support more complex and globally relevant pharmaceutical solutions.

Mission and vision

Mission: ACI HealthCare Limited aims to achieve business excellence through quality by planning, implementing, controlling and continuously improving the standards of its products and services to exceed customer expectations.

Vision: The company aims to contribute to improved quality of life and well-being through the responsible application of knowledge and skills.

Leadership and governance

ACI HealthCare Limited describes its governance philosophy around accountability, regulatory discipline and ethical decision-making. Its leadership framework is intended to ensure that operational, scientific and strategic activities remain focused on patient well-being, product quality and responsible growth.

As a public limited subsidiary of ACI PLC, the company states that its governance structure incorporates corporate transparency, data integrity and performance oversight. Decision-making is guided by structured risk evaluation, policy adherence and continuous improvement principles.

Registration and location

• Company name: ACI HealthCare Limited
• Established: 18 February 2013
• Headquarters: Treepordi, Sonargaon
• DGDA registered address: Treepordi, Sonargaon
• DGDA status: Functional
• Licence category: Allopathic
• Manufacturing location: Sonargaon, Narayanganj
• Manufacturing campus: Approximately 39 acres

Why ACI HealthCare Limited matters

ACI HealthCare Limited represents the healthcare manufacturing arm of a diversified Bangladeshi business group and has a stated focus on regulated pharmaceutical markets. Its manufacturing strategy combines controlled production environments, quality governance and regulatory alignment with an ambition to participate in international pharmaceutical supply chains.